BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

217 related articles for article (PubMed ID: 17442231)

  • 21. Potential combination chemotherapy approaches for advanced adult-type soft-tissue sarcoma.
    Kopp HG; Patel S; Brücher B; Hartmann JT
    Am J Clin Dermatol; 2008; 9(4):207-17. PubMed ID: 18572972
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Fifty years of advances in sarcoma treatment: moving the needle from conventional chemotherapy to targeted therapy.
    Patel SR
    Am Soc Clin Oncol Educ Book; 2014; ():259-62. PubMed ID: 24857084
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Role of neoadjuvant chemotherapy in intermediate/high-grade soft-tissue sarcomas in the adult].
    Mori S; Apice G; Ottaiano A; De Chiara A; Germano A; Botti G; De Rosa V; Ravo V; Morrica B; Mozzillo N
    Tumori; 2003; 89(4 Suppl):267-8. PubMed ID: 12903615
    [No Abstract]   [Full Text] [Related]  

  • 24. Vorinostat in refractory soft tissue sarcomas - Results of a multi-centre phase II trial of the German Soft Tissue Sarcoma and Bone Tumour Working Group (AIO).
    Schmitt T; Mayer-Steinacker R; Mayer F; Grünwald V; Schütte J; Hartmann JT; Kasper B; Hüsing J; Hajda J; Ottawa G; Mechtersheimer G; Mikus G; Burhenne J; Lehmann L; Heilig CE; Ho AD; Egerer G
    Eur J Cancer; 2016 Sep; 64():74-82. PubMed ID: 27367154
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Chemotherapy of sarcomas: optimization of existing drugs and new molecules].
    Fayette J; Blay JY
    Cancer Radiother; 2006; 10(1-2):72-7. PubMed ID: 16324867
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Role of chemotherapy in the treatment of soft tissue sarcoma in adults].
    Bui NB; Coindre JM; Chauvergne J; Maree D; Denepoux R; Mage P
    J Chir (Paris); 1986 Jan; 123(1):53-8. PubMed ID: 3514642
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Current Molecular Targeted Therapies for Bone and Soft Tissue Sarcomas.
    Nakano K; Takahashi S
    Int J Mol Sci; 2018 Mar; 19(3):. PubMed ID: 29510588
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Therapeutic Targets for Bone and Soft-Tissue Sarcomas.
    Miwa S; Yamamoto N; Hayashi K; Takeuchi A; Igarashi K; Tsuchiya H
    Int J Mol Sci; 2019 Jan; 20(1):. PubMed ID: 30621224
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Novel treatment strategies for soft tissue sarcoma.
    Kasper B; Gil T; D'Hondt V; Gebhart M; Awada A
    Crit Rev Oncol Hematol; 2007 Apr; 62(1):9-15. PubMed ID: 17141519
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Drug therapy for soft tissue sarcoma].
    Zhang X
    Zhonghua Yi Xue Za Zhi; 2019 Oct; 99(37):2889-2892. PubMed ID: 31607015
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Chemotherapy in advanced soft tissue sarcomas.
    Verweij J; van Groeningen CJ; Pinedo HM
    Cancer Treat Res; 1989; 44():75-92. PubMed ID: 2577163
    [No Abstract]   [Full Text] [Related]  

  • 32. New emerging drugs in soft tissue sarcoma.
    Milano A; Apice G; Ferrari E; Fazioli F; de Rosa V; de Luna AS; Iaffaioli RV; Caponigro F
    Crit Rev Oncol Hematol; 2006 Jul; 59(1):74-84. PubMed ID: 16533604
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Treatment-induced pathologic necrosis: a predictor of local recurrence and survival in patients receiving neoadjuvant therapy for high-grade extremity soft tissue sarcomas.
    Eilber FC; Rosen G; Eckardt J; Forscher C; Nelson SD; Selch M; Dorey F; Eilber FR
    J Clin Oncol; 2001 Jul; 19(13):3203-9. PubMed ID: 11432887
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Medical treatment of soft-tissue sarcomas in adults].
    Lucas P; Spielmann M
    Bull Cancer; 1985; 72(3):183-201. PubMed ID: 3907733
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Genetic predictors for drug resistance in soft tissue sarcoma: a review of publications in 2004.
    Fayette J; Blay JY
    Curr Opin Oncol; 2005 Jul; 17(4):370-5. PubMed ID: 15933471
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Current therapeutic standards in advanced soft tissue sarcomas].
    Burkhard-Meier A; Berclaz LM; Di Gioia D; Lindner LH
    Dtsch Med Wochenschr; 2024 Mar; 149(6):303-307. PubMed ID: 38412986
    [TBL] [Abstract][Full Text] [Related]  

  • 37. New and emerging therapies for advanced or metastatic soft tissue sarcoma.
    Gettys SC; Anderson JE; Davis JE
    J Oncol Pharm Pract; 2014 Aug; 20(4):288-97. PubMed ID: 24022407
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Systemic treatment of advanced or metastatic soft tissue sarcomas.
    Verweij J; Pinedo HM
    Cancer Treat Res; 1991; 56():75-91. PubMed ID: 1681881
    [No Abstract]   [Full Text] [Related]  

  • 39. Soft tissue sarcomas: are all soft tissue sarcomas treated with the same drugs?
    Blay JY; Cassier PA; Ray-Coquard I
    Eur J Cancer; 2011 Sep; 47 Suppl 3():S385-8. PubMed ID: 21944026
    [No Abstract]   [Full Text] [Related]  

  • 40. Results of single-agent and combination chemotherapy for advanced soft tissue sarcomas. Implications for decision making in the clinic.
    Demetri GD; Elias AD
    Hematol Oncol Clin North Am; 1995 Aug; 9(4):765-85. PubMed ID: 7490240
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.